120 related articles for article (PubMed ID: 15274362)
1. Profile of cytokines produced in tumor tissue after administration of cyclophosphamide in a combination therapy with tumor necrosis factor.
Takiguchi K; Nakamoto T; Inagawa H; Kohchi C; Nishizawa T; Nagasue N; Soma G
Anticancer Res; 2004; 24(3a):1823-8. PubMed ID: 15274362
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamide.
Inagawa H; Ohshiro S; Nishizawa T; Goto S; Soma G; Mizuno D
Anticancer Res; 1997; 17(1A):55-60. PubMed ID: 9066630
[TBL] [Abstract][Full Text] [Related]
4. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunological analysis of innate immunity activation after oral administration of wheat fermented extract to teleost fish.
Kadowaki T; Yasui Y; Takahashi Y; Kohchi C; Soma G; Inagawa H
Anticancer Res; 2009 Nov; 29(11):4871-7. PubMed ID: 20032450
[TBL] [Abstract][Full Text] [Related]
7. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells.
Park YG; Kang SK; Kim WJ; Lee YC; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472
[TBL] [Abstract][Full Text] [Related]
8. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
Sacchi A; Gasparri A; Curnis F; Bellone M; Corti A
Cancer Res; 2004 Oct; 64(19):7150-5. PubMed ID: 15466213
[TBL] [Abstract][Full Text] [Related]
9. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
Inagawa H; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
Fukuda T; Hisadome M; Komatsu H
J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
[TBL] [Abstract][Full Text] [Related]
12. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia.
Zhu Y; Saito K; Murakami Y; Asano M; Iwakura Y; Seishima M
Neurosci Lett; 2006 Jan; 393(2-3):122-6. PubMed ID: 16356636
[TBL] [Abstract][Full Text] [Related]
13. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines.
Okunieff P; Xu J; Hu D; Liu W; Zhang L; Morrow G; Pentland A; Ryan JL; Ding I
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):890-8. PubMed ID: 16751071
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
Ji Q; Zhang L; Jia H; Xu J
Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
[TBL] [Abstract][Full Text] [Related]
15. [Expression of non-T cell derived cytokines in acute rejection after heart transplantation: experiment with mouse model].
Liang TB; Yu ZY; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):26-30. PubMed ID: 16606531
[TBL] [Abstract][Full Text] [Related]
16. Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12.
Pressley JS; Elgert KD
Cancer Invest; 2006; 24(4):351-9. PubMed ID: 16777686
[TBL] [Abstract][Full Text] [Related]
17. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
18. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
19. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom.
da Silva RJ; da Silva MG; Vilela LC; Fecchio D
Mediators Inflamm; 2002 Aug; 11(4):197-201. PubMed ID: 12396470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
